vs
Side-by-side financial comparison of Eos Energy Enterprises, Inc. (EOSE) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
Eos Energy Enterprises, Inc. is the larger business by last-quarter revenue ($58.0M vs $57.3M, roughly 1.0× RHYTHM PHARMACEUTICALS, INC.). RHYTHM PHARMACEUTICALS, INC. runs the higher net margin — -83.0% vs -207.7%, a 124.7% gap on every dollar of revenue. On growth, Eos Energy Enterprises, Inc. posted the faster year-over-year revenue change (699.6% vs 36.9%).
Eos Energy Enterprises, Inc. is an energy storage solutions provider that designs, produces and deploys safe long-duration zinc-based battery systems. It serves utility, commercial, industrial and microgrid customers across North America, Europe and Asia, supporting grid stability and renewable energy integration.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
EOSE vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.0M | $57.3M |
| Net Profit | $-120.5M | $-47.5M |
| Gross Margin | -93.8% | 91.6% |
| Operating Margin | -140.1% | -82.2% |
| Net Margin | -207.7% | -83.0% |
| Revenue YoY | 699.6% | 36.9% |
| Net Profit YoY | 55.1% | -9.6% |
| EPS (diluted) | $-0.53 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.0M | $57.3M | ||
| Q3 25 | $30.5M | $51.3M | ||
| Q2 25 | $15.2M | $48.5M | ||
| Q1 25 | $10.5M | $32.7M | ||
| Q4 24 | $7.3M | $41.8M | ||
| Q3 24 | — | $33.3M | ||
| Q2 24 | — | $29.1M | ||
| Q1 24 | — | $26.0M |
| Q4 25 | $-120.5M | $-47.5M | ||
| Q3 25 | $-641.4M | $-52.9M | ||
| Q2 25 | $-222.9M | $-46.6M | ||
| Q1 25 | $15.1M | $-49.5M | ||
| Q4 24 | $-268.1M | $-43.3M | ||
| Q3 24 | — | $-43.6M | ||
| Q2 24 | — | $-32.3M | ||
| Q1 24 | — | $-141.4M |
| Q4 25 | -93.8% | 91.6% | ||
| Q3 25 | -111.2% | 89.3% | ||
| Q2 25 | -203.2% | 88.6% | ||
| Q1 25 | -234.7% | 88.8% | ||
| Q4 24 | -324.0% | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | -140.1% | -82.2% | ||
| Q3 25 | -200.6% | -102.6% | ||
| Q2 25 | -419.1% | -93.4% | ||
| Q1 25 | -506.2% | -143.7% | ||
| Q4 24 | -712.8% | -98.6% | ||
| Q3 24 | — | -132.0% | ||
| Q2 24 | — | -139.2% | ||
| Q1 24 | — | -538.7% |
| Q4 25 | -207.7% | -83.0% | ||
| Q3 25 | -2102.1% | -103.1% | ||
| Q2 25 | -1463.2% | -96.1% | ||
| Q1 25 | 144.7% | -151.4% | ||
| Q4 24 | -3696.7% | -103.6% | ||
| Q3 24 | — | -131.2% | ||
| Q2 24 | — | -110.9% | ||
| Q1 24 | — | -544.4% |
| Q4 25 | $-0.53 | $-0.73 | ||
| Q3 25 | $-4.91 | $-0.82 | ||
| Q2 25 | $-1.05 | $-0.75 | ||
| Q1 25 | $-0.20 | $-0.81 | ||
| Q4 24 | $-2.30 | $-0.71 | ||
| Q3 24 | — | $-0.73 | ||
| Q2 24 | — | $-0.55 | ||
| Q1 24 | — | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $568.0M | $388.9M |
| Total DebtLower is stronger | $813.3M | — |
| Stockholders' EquityBook value | $-2.2B | $139.1M |
| Total Assets | $885.2M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $568.0M | $388.9M | ||
| Q3 25 | $58.7M | $416.1M | ||
| Q2 25 | $120.2M | $291.0M | ||
| Q1 25 | $82.6M | $314.5M | ||
| Q4 24 | $74.3M | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M | ||
| Q1 24 | — | $201.2M |
| Q4 25 | $813.3M | — | ||
| Q3 25 | $448.5M | — | ||
| Q2 25 | $445.3M | — | ||
| Q1 25 | $325.5M | — | ||
| Q4 24 | $316.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-2.2B | $139.1M | ||
| Q3 25 | $-2.3B | $148.8M | ||
| Q2 25 | $-1.1B | $-11.9M | ||
| Q1 25 | $-942.2M | $18.9M | ||
| Q4 24 | $-1.1B | $21.7M | ||
| Q3 24 | — | $11.2M | ||
| Q2 24 | — | $39.3M | ||
| Q1 24 | — | $61.6M |
| Q4 25 | $885.2M | $480.2M | ||
| Q3 25 | $328.2M | $506.9M | ||
| Q2 25 | $361.0M | $372.7M | ||
| Q1 25 | $263.3M | $386.7M | ||
| Q4 24 | $260.3M | $392.3M | ||
| Q3 24 | — | $363.6M | ||
| Q2 24 | — | $381.8M | ||
| Q1 24 | — | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-50.3M | $-25.4M |
| Free Cash FlowOCF − Capex | $-75.2M | — |
| FCF MarginFCF / Revenue | -129.7% | — |
| Capex IntensityCapex / Revenue | 43.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-265.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-50.3M | $-25.4M | ||
| Q3 25 | $-65.9M | $-26.6M | ||
| Q2 25 | $-66.1M | $-23.3M | ||
| Q1 25 | $-28.9M | $-40.4M | ||
| Q4 24 | $-42.7M | $-18.8M | ||
| Q3 24 | — | $-25.2M | ||
| Q2 24 | — | $-29.1M | ||
| Q1 24 | — | $-40.7M |
| Q4 25 | $-75.2M | — | ||
| Q3 25 | $-82.7M | — | ||
| Q2 25 | $-73.2M | — | ||
| Q1 25 | $-33.8M | — | ||
| Q4 24 | $-55.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -129.7% | — | ||
| Q3 25 | -271.1% | — | ||
| Q2 25 | -480.2% | — | ||
| Q1 25 | -323.6% | — | ||
| Q4 24 | -769.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 43.1% | — | ||
| Q3 25 | 55.2% | — | ||
| Q2 25 | 46.2% | — | ||
| Q1 25 | 47.0% | — | ||
| Q4 24 | 180.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -1.91× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
